TZ-Ab101

N/A

Report date: 2025/11/24 11:18:12

Base Information

Drug NameTZ-Ab101
Drug Alias NameTZ-Ab101
ClassificationBiologics > Protein drugs
Mechanisms of ActionKRAS G12D inhibitors
TargetsKRAS G12D
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTherazyne Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTherazyne Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A